Provided by Tiger Fintech (Singapore) Pte. Ltd.

Athira Pharma, Inc.

0.3353
+0.01735.44%
Post-market: 0.33960.0043+1.28%19:11 EDT
Volume:118.85K
Turnover:39.46K
Market Cap:13.09M
PE:-0.13
High:0.3398
Open:0.3180
Low:0.3170
Close:0.3180
Loading ...

Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained

TIPRANKS
·
03 Mar

Athira Pharma’s 2024 Financial Results and Pipeline Progress

TIPRANKS
·
01 Mar

Athira Pharma (ATHA) Gets a Hold from JMP Securities

TIPRANKS
·
28 Feb

Athira Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Athira Pharma FY 2024 GAAP EPS $(2.52) Beats $(2.54) Estimate

Benzinga
·
28 Feb

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire
·
28 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
24 Feb

Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
18 Feb

Terra Uranium unveils co-ordinated exploration strategy for Athabasca Basin

Small Caps
·
06 Feb

Terra Uranium Expands Uranium Exploration with Strategic Partnerships

TIPRANKS
·
30 Jan

Terra Uranium well placed to accelerate Canadian strategy in 2025

Small Caps
·
30 Jan

Can Athira Pharma (NASDAQ:ATHA) Afford To Invest In Growth?

Simply Wall St.
·
28 Jan

Athira Pharma to pay $4M to settle False Claims Act allegations

TIPRANKS
·
07 Jan

Athira Pharma to Pay $4 Million Over Alleged Research Misconduct

Dow Jones
·
07 Jan

BRIEF-US says Athira Pharma to pay $4 mln to settle allegations of scientific research misconduct

Reuters
·
07 Jan

U.S. Justice Department Says Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research Misconduct

THOMSON REUTERS
·
07 Jan